Home Procurement NewsJ&J to buy neurological drugmaker Intra-Cellular for $14.6 billion

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion

January 13, 2025•

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for $14.6 billion, boosting its market for neurological disorder treatments.

Was this article helpful?
YesNo

Last modified: January 13, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Search Window
↑